Bai Jingmin, Wang Jinyuan, Wang Chengcheng, Dai Xiangkun, Yu Wei, Pan Longsheng, Qu Baolin
Department of Radiation Oncology, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Department of Neurosurgery, The First Medical Center of the Chinese People's Liberation Army (PLA) General Hospital, Beijing, CHN.
Cureus. 2025 Jun 20;17(6):e86427. doi: 10.7759/cureus.86427. eCollection 2025 Jun.
This article reports two cases of meningioma patients treated with the novel radiosurgical device ZAP-X stereotactic radiosurgery. During the long-term follow-up period of up to four years after treatment, neither patient developed new neurological deficits, and no adverse reactions of Common Terminology Criteria for Adverse Events grade 2 or above occurred. By retrospectively analyzing the clinical diagnosis, treatment processes, and follow-up results of these two patients, this study aims to provide practical references for the large-scale clinical application of this technology.
本文报道了两例使用新型放射外科设备ZAP-X立体定向放射外科治疗的脑膜瘤患者。在治疗后长达四年的长期随访期内,两名患者均未出现新的神经功能缺损,也未发生2级或以上的不良事件通用术语标准不良反应。通过回顾性分析这两名患者的临床诊断、治疗过程和随访结果,本研究旨在为该技术的大规模临床应用提供实用参考。